Contact

Read the Latest Blog Posts

Top five sun and skin myths (part...

There are a number of misconceptions about the interaction between sunlight and skin. In this two part post... Read more...

Low sunscreen use, high melanoma ...

It’s estimated that more than 9,000 Americans will die from melanoma this year and 76,000 new cases of the... Read more...

Photoaging ...

Young adults are the age group most likely to seek a tan, with research showing that people under the age of... Read more...

Watch the Latest Videos

Part Four - The impact of Erythro...

Mikey's quality of life, like all patients with Erythropoietic Protoporphyria (EPP), is severely affected. Severe pain f... Watch now

Quick! I need Sunburn Relief! Rem...

There are many remedies available to help provide relief from the symptoms of sunburn. Treatment of sunburn can include:... Watch now

Understanding Vitiligo - Causes &...

Vitiligo is a common pigmentary disorder in which the pigment producing cells of the skin (melanocytes) are absent or do... Watch now

Clinuvel in Focus

The technology behind Clinuvel’s lead drug, SCENESSE® (afamelanotide), has been in research and development since the 1980s when a small team of scientists set out to investigate methods of preventing skin cancer in humans. Clinuvel licensed this technology an... Read more

Clinuvel on Twitter

Content Tags

Connect with Clinuvel

Clinuvel Online Coverage